Literature DB >> 16557967

Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

T R Kozel1, J Cazin.   

Abstract

A weakly virulent nonencapsulated variant of Cryptococcus neoformans is described. The chemical structure and antigenicity of the soluble polysaccharides produced by the variant strain and a typical virulent strain were compared. The soluble polysaccharides produced by both strains were composed of the same constituent monosaccharides; however, the virulent strain produced a polysaccharide having a greater uronic acid content and a larger molecular size than that of the variant strain. Soluble polysaccharides from the two strains are not closely related immunologically. Soluble polysaccharide obtained from the virulent strain did not affect persistence of the variant strain in mice.

Entities:  

Year:  1971        PMID: 16557967      PMCID: PMC416145          DOI: 10.1128/iai.3.2.287-294.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS.

Authors:  H H GADEBUSCH; P A WARD; E P FRENKEL
Journal:  J Infect Dis       Date:  1964-02       Impact factor: 5.226

2.  CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.

Authors:  J E BENNETT; H F HASENCLEVER
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Studies of proteins and antibodies by specific hemagglutination and hemolysis of proteinconjugated erythrocytes.

Authors:  A B STAVITSKY; E R ARQUILLA
Journal:  Int Arch Allergy Appl Immunol       Date:  1958

4.  Taxonomy of Cryptococcus neoformans and its variety uniguttulatus.

Authors:  N J KREGER-VAN RIJ
Journal:  Antonie Van Leeuwenhoek       Date:  1961       Impact factor: 2.271

5.  Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies.

Authors:  A KASE; J F METZGER
Journal:  J Bacteriol       Date:  1962-04       Impact factor: 3.490

6.  The genus Cryptococcus.

Authors:  R W BENHAM
Journal:  Bacteriol Rev       Date:  1956-09

7.  The use of gastric mucin to lower resistance of laboratory animals to systemic fungus infections.

Authors:  R E STRAUSS; A M KLIGMAN
Journal:  J Infect Dis       Date:  1951 Mar-Apr       Impact factor: 5.226

8.  Cryptococcosis due to an unusually slow-growing organism.

Authors:  A Widra; G Van Horn
Journal:  Am J Med Technol       Date:  1967 Sep-Oct

9.  Cryptococcus neoformans. I. Nonencapsulated mutants.

Authors:  G S Bulmer; M D Sans; C M Gunn
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.

Authors:  F Farhi; G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

View more
  82 in total

Review 1.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

2.  Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.

Authors:  M A Wilson; T R Kozel
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Expression of capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Rui Kano; Shinichi Watanabe; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

5.  Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

Authors:  R Blackstock; J W Murphy
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 6.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

7.  Immunogenic fractions of Cryptococcus neoformans.

Authors:  J R Graybill; D C Straus; T J Nealon; M Hague; R E Paque
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

8.  Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Authors:  H S Emery; C P Shelburne; J P Bowman; P G Fallon; C A Schulz; E S Jacobson
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.